Biopharmaceuticals Contract Manufacturing Global Market Report 2024
May 21, 2024 04:01 ET
|
Research and Markets
Dublin, May 21, 2024 (GLOBE NEWSWIRE) -- The "Biopharmaceuticals Contract Manufacturing Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The biopharmaceuticals...
Monoclonal Antibody Collaboration, Development, Research and Licensing Deals Analysis Report 2024 with Directory of 970+ Agreements Signed Since 2014
May 07, 2024 06:55 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Monoclonal Antibody Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Monoclonal Antibody...
599 Cancer Monoclonal Antibody Collaboration and Licensing Deals Report and Directory 2016-2024
May 07, 2024 06:35 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Cancer Monoclonal Antibody Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering.Cancer Monoclonal...
COVID-19 Drug Pipeline Landscape Report 2024: Comprehensive Insights on 400+ Companies and 400+ Pipeline Drugs
April 16, 2024 05:02 ET
|
Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "COVID-19 - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This "COVID-19 - Pipeline Insight, 2024,"...
CDK9 inhibitor Drug Pipeline Research Report 2024
April 12, 2024 07:29 ET
|
Research and Markets
Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "CDK9 inhibitor - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering."Cyclin-Dependent Kinase 9 (CDK9)...
Antibody Therapeutics (Monoclonal, Polyclonal, Antibody Fragment, Bispecific) Market Research 2023: Advancements in Antibody Engineering and Growing Focus on Collaborations for Drug Discovery
April 04, 2024 04:12 ET
|
Research and Markets
Dublin, April 04, 2024 (GLOBE NEWSWIRE) -- The "Global Antibody Therapeutics Market by Format (Monoclonal, Polyclonal, Antibody Fragment, Bispecific), Disease Area (Oncology, Autoimmune &...
COSENTYX (Secukinumab) Market Analysis and Outlook 2019-2032: Mechanism, Dosage, Research, Sales, Regulatory Milestones, Patents, SWOT Analysis
April 02, 2024 11:47 ET
|
Research and Markets
Dublin, April 02, 2024 (GLOBE NEWSWIRE) -- The "COSENTYX Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...
Monoclonal Antibodies in Veterinary Health: Global and Regional Market Analysis by Animal Type, Application, End User, and Country - Forecast to 2033
March 18, 2024 05:49 ET
|
Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibodies in Veterinary Health Market: Focus on Animal Type, Application, and End User, Regional Analysis, and Competitive...
Global Therapeutic Antibody Market Research, 2019-2023 and 2024-2029
February 27, 2024 10:04 ET
|
Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Global Therapeutic Antibody Market (2023 Edition): Analysis By Antibody Type (Monoclonal, Bispecific, Drug Conjugates, Others), Source (Fully human,...
Dyadic Advances Collaboration with Israel Institute for Biological Research (IIBR) Targeting Bio-Threats and Emerging Disease Solutions
February 21, 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla. and NES-ZIONA, Israel, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ: DYAI), a global biotechnology company specializing in advanced...